These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57. Rosiglitazone, marketing, and medical science. Moynihan R BMJ; 2010 Apr; 340():c1848. PubMed ID: 20375091 [No Abstract] [Full Text] [Related]
58. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention. Vanchieri C J Natl Cancer Inst; 2005 Apr; 97(8):552-3. PubMed ID: 15840872 [No Abstract] [Full Text] [Related]
59. FDA's role in drug product recalls. Crawford SY Am J Hosp Pharm; 1991 Dec; 48(12):2595-6. PubMed ID: 1814194 [No Abstract] [Full Text] [Related]
60. The COX-2 controversy continues ...but NSAIDs are still in the lead. New studies shed light on risks associated with popular arthritis painkillers. Health News; 2006 Aug; 12(8):3-4. PubMed ID: 16913025 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]